Maharaja & Speedex India reported a 34.5% jump in revenue and a 42.9% rise in net profit for Q2 FY27, driven by newly added manufacturing lines.
Maharaja & Speedex India delivered robust Q2 FY27 results, with revenue rising 34.5% and net profit up 42.9% year-on-year. The growth was powered by its expanded manufacturing capacity and a favorable regulatory environment.
Maharaja & Speedex India’s first earnings call since its September IPO framed the quarter around a simple test: could new capacity translate into sales before competitors caught up? The answer was a clear yes, with revenue hitting ₹78 crore and profit reaching ₹10 crore.
The numbers show broad-based strength. Revenue grew 35% from a year ago, while net profit climbed 43%. The net profit margin improved by 70 basis points to 12.8%, indicating that growth came with better profitability.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ2 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|
| Revenue (₹ Cr) | 78.0YoY +34% | 58.0 |
| Profit (₹ Cr) | 10.0YoY +43% | 7.0 |
| Net Profit Margin | 12.8%YoY +5.8% | 12.1% |
Management, in its earnings call covered by StockWatch, attributed the surge to capacity-led volume growth. New lines added in February ramped up to 95% efficiency, lifting annual capacity to 72 lakh units. An 8% price hike also contributed, according to the Q&A transcript from Sovrenn.
The profit growth outpaced sales thanks to operating leverage. A shift to more in-house manufacturing boosted gross margins, while debt repayment from IPO proceeds kept interest costs flat. Depreciation doubled due to the new machinery, but this was more than offset by the revenue surge.
Looking ahead, the company is confident but vague. CEO Akash Agarwal told analysts the firm is targeting over 45% revenue growth for FY27, as noted by ALFA Finder. This implies a sharp acceleration in the second half.
Live Chart
· SPEEDEX
(BSE)
ISIN: INE0SVD01012
The roadmap, however, lacks specific quarterly targets. Management later clarified that EBITDA margins would likely stabilize around 19-20%, not expand further, as economies of scale offset gains from a shift toward higher-margin own-brand sales.
Key Points
The quarter validates the capacity-expansion thesis that underpinned the recent IPO. Growth is real and margins are healthy. The catch is in the forward view. Achieving the guided acceleration means the new lines must hit their utilization targets without a hitch, and the planned shift toward own-brand sales must gain traction.
Investors are left weighing solid execution against aspirational guidance. The stock trades at a discount to the industry, but that gap will close only if the company delivers the steep second-half ramp it has promised.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.